Quantcast

Latest Vagus nerve stimulation Stories

2011-08-15 07:00:00

HOUSTON, Aug. 15, 2011 /PRNewswire/ -- Cyberonics, Inc. (NASDAQ:CYBX), a global leader in devices for epilepsy management, announced today that it has voluntarily stopped shipment and is retrieving field inventory of its Aspire platform generators, Models 105 and 106. The company does not believe that the generators pose a health risk to patients, but initiated this action when it discovered that stimulation output current delivered to patients can be less than the output current...

2011-08-12 06:53:03

(Ivanhoe Newswire) -- There may be a new treatment for obstructive sleep apnea (OSA) on the horizon. Researchers have received approval from the FDA to begin a clinical trial to evaluate an investigational device known as the Hypoglossal Nerve Stimulation (HGNS) System. According to the World Health Organization, about 100 million people worldwide suffer from OSA. It happens because of a blockage of breathing during sleep, which can deprive patients of deep sleep and lead to a variety of...

2011-08-09 08:00:00

HOUSTON, Aug. 9, 2011 /PRNewswire/ -- Cyberonics, Inc. (Nasdaq: CYBX) today announced that the company will report financial results for the first quarter ended July 29, 2011 of its fiscal year ending April 27, 2012, on Thursday, August 25, 2011, before regular market trading hours. The company will conduct a conference call to discuss those results on the same day at 8:00 AM Central Time (9:00 AM Eastern Time). Fiscal Year 2012 First Quarter Results Conference Call Instructions The...

2011-08-02 08:17:00

ST. PAUL, Minn., Aug. 2, 2011 /PRNewswire/ -- Apnex Medical, Inc., received investigational device exemption (IDE) approval from the U.S. Food and Drug Administration (FDA) to begin a clinical study to evaluate the safety and effectiveness of its Hypoglossal Nerve Stimulation (HGNS®) System to treat obstructive sleep apnea (OSA). Data from this clinical study are intended to support the Pre-Market Approval (PMA) application for the HGNS System to the FDA. "Many patients...

2011-05-25 08:00:00

HOUSTON, May 25, 2011 /PRNewswire/ -- Cyberonics, Inc. (NASDAQ: CYBX), a global leader in epilepsy management, today announced it will participate in the 2011 Jefferies Global Healthcare Conference on Wednesday, June 8, 2011, in New York. Greg Browne, Cyberonics' Senior Vice President, Finance & Chief Financial Officer, will speak to the attendees of the conference at 10:30 AM Eastern Time. A live audio webcast of the presentation can be accessed by clicking on the Investor Relations...


Word of the Day
tesla
  • The unit of magnetic flux density in the International System of Units, equal to the magnitude of the magnetic field vector necessary to produce a force of one newton on a charge of one coulomb moving perpendicular to the direction of the magnetic field vector with a velocity of one meter per second. It is equivalent to one weber per square meter.
This word is named for Nikola Tesla, the inventor, engineer, and futurist.